Abnormal_JJ
T_NN
lymphocyte_NN
development_NN
induced_VBD
by_IN
targeted_VBN
overexpression_NN
of_IN
IkappaB_NN
alpha_NN
._.

A_DT
role_NN
in_IN
thymic_JJ
maturation_NN
for_IN
factors_NNS
of_IN
the_DT
NF-kappaB_NN
family_NN
has_VBZ
long_RB
been_VBN
suspected_VBN
,_,
but_CC
not_RB
yet_RB
proven_VBN
._.

Transgenic_JJ
mice_NNS
with_IN
a_DT
lymphocyte-specific_JJ
defect_NN
in_IN
NF-kappaB_NN
activation_NN
were_VBD
produced_VBN
by_IN
targeted_VBN
expression_NN
of_IN
human_JJ
IkappaB_NN
alpha_NN
._.

The_DT
thymic_JJ
cellularity_NN
of_IN
these_DT
mice_NNS
was_VBD
significantly_RB
decreased_VBN
._.

The_DT
proportion_NN
of_IN
mature_JJ
,_,
TCRhigh_JJ
thymocytes_NNS
of_IN
the_DT
alphabeta_NN
lineage_NN
was_VBD
reduced_VBN
,_,
and_CC
the_DT
remaining_VBG
TCRhigh_JJ
population_NN
contained_VBD
an_DT
unusually_RB
high_JJ
proportion_NN
of_IN
double-positive_JJ
cells_NNS
._.

This_DT
defect_NN
in_IN
maturation_NN
resulted_VBD
in_IN
a_DT
transgene_NN
dose-dependent_JJ
reduction_NN
in_IN
peripheral_JJ
T_NN
lymphocytes_NNS
,_,
with_IN
the_DT
CD8_NN
lineage_NN
being_VBG
more_RBR
severely_RB
affected_VBN
._.

These_DT
data_NNS
provide_VBP
direct_JJ
evidence_NN
for_IN
the_DT
involvement_NN
of_IN
NF-kappaB\/Rel_NN
family_NN
proteins_NNS
in_IN
late_JJ
stages_NNS
of_IN
T_NN
lymphocyte_NN
development_NN
,_,
coincident_JJ
with_IN
positive_JJ
and_CC
negative_JJ
selection_NN
._.

